|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C12Q 1/68 | (2018.01) |
| (11) | Number of the document | 3277842 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16757791.5 |
| Date of filing the European patent application | 2016-08-16 | |
| (97) | Date of publication of the European application | 2018-02-07 |
| (45) | Date of publication and mention of the grant of the patent | 2019-07-10 |
| (46) | Date of publication of the claims translation | 2019-10-25 |
| (86) | Number | PCT/US2016/047140 |
| Date | 2016-08-16 |
| (87) | Number | WO 2017/031101 |
| Date | 2017-02-23 |
| (30) | Number | Date | Country code |
| 201562206194 P | 2015-08-17 | US | |
| 201562218927 P | 2015-09-15 | US | |
| 201562241019 P | 2015-10-13 | US | |
| 201662310582 P | 2016-03-18 | US | |
| 201662372662 P | 2016-08-09 | US |
| (72) |
GUALBERTO, Antonio, US
SCHOLZ, Catherine, Rose, US
|
| (73) |
Kura Oncology, Inc.,
3033 Science Park Road, Suite 220, San Diego, CA 92121,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Vėžio pacientų gydymo būdai farneziltransferazės inhibitoriais |
| METHODS OF TREATING CANCER PATIENTS WITH FARNESYL TRANSFERASE INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2021-07-22 | 6 | 139.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2022-08-16 |